Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| C22H22N6O7S2 | 1000980-60-8 | Details |
| C25H35FO8S | 2367-73-9 | Details |
| C17H26N4O6S | 1026075-53-5 | Details |
| LXI-15028-02 | C18H19N3O2 | 1640981-20-9 | Details |
| C20H19F2N3O3 | 942195-56-4 | Details |
| C24H33FO6 | 1524-86-3 | Details |
| 1-((2-hydroxyethyl)amino)-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol | 1415561-33-9 | Details |
| C17H12ClNO4 | 1421312-33-5 | Details |
| C13H12O2 | 5234-06-0 | Details |
| C13H14O3 | 34646-56-5 | Details |
| C15H19NO2 | 2111-24-2 | Details |
| C16H11NO4 | 2376195-48-9 | Details |
| C10H7NO4 | 22235-04-7 | Details |
| C18H20O4 | 91401-73-9 | Details |
| C15H17N3O5 | 1616563-62-2 | Details |
| Trazodone Impurity J | C19H22Cl3N5O | 1263278-79-0 | Details |
| Candesartan Cilexetil EP IMpurity G | C24H20N6O3 | 139481-59-7 | Details |
| Trazodone Impurity E | C21H26ClN5O | 1346599-35-6 | Details |
| Doxapram EP Impurity A | C20H22ClNO | 3192-64-1 | Details |
| Details |
| (1R,2S,3S)-Aprepitant | C23H21F7N4O3 | 172822-28-5 | Details |
| Aprepitant Impurity 8 HCl | C20H19ClF7NO2 | 1333998-27-8 | Details |
| Olmesartan Medoxomil EP Impurity D | C48H44N6O6 | 1020157-01-0 | Details |
| Methyl 3-(3,4-dihydroxyphenyl)propanoate | C10H12O4 | 3598-22-9 | Details |
| Landiolol Impurity 18 | C44H66N6O13 | 1582797-17-8 | Details |
| (1R,2S,3R)-Aprepitant | C23H21F7N4O3 | 1185502-97-9 | Details |
| 2-(R)-[1-(S)-(3,5-Bis(trifluoroMethyl)phenyl)ethoxy]-3-(S)-fluorophenylMorpholine | C20H18F7NO2 | 170729-79-0 | Details |
| (S)-(((1-(6-aMino-9H-purin-9-yl)propan-2-yloxy)Methyl)phosphoryl)bis(oxy)bis(Methylene) isopropyl dicarbonate fuMarate | C20H22N5O16P | 1432630-26-6 | Details |
| C20H11Cl2F2N5O2 | 2044702-52-3 | Details |
| C19H42N2 | 94107-99-0 | Details |
| C13H15N3O4 | 2197420-75-8 | Details |
| C19H16N2O5 | 808118-34-5 | Details |
| 421312-35-7 | Details |
| C25H28N6O7S3 | 878002-86-9 | Details |
| C19H16N2O5 | 2599284-48-5 | Details |
| C23H34O2 | 301-01-9 | Details |
| Fructosazine | C12H20N2O8 | 13185-73-4 | Details |
| Bromocriptine mesylate | C33H44BrN5O8S | 22260-51-1 | Details |
| 1,2-Dinitroglycerin | C3H6N2O7 | 621-65-8 | Details |
| 1,3-Dinitroglycerin | C3H6N2O7 | 623-87-0 | Details |
| Candesartan Cilexetil EP Impurity F | C35H38N6O6 | 914613-36-8 | Details |
| Hydrochlorothiazide EP Impurity C | C15H16Cl2N6O8S4 | 402824-96-8 | Details |
| Candesartan Cilexetil EP Impurity D | C33H34N6O6 | 1185256-03-4 | Details |
| Candesartan Cilexetil EP Impurity E | C35H38N6O6 | 914613-35-7 | Details |
| 4-Amino-6-chlorobenzene-1,3-disulfonamide | C6H8ClN3O4S2 | 121-30-2 | Details |
| Rosuvastatin calcium | C22H30CaFN3O6S | 147098-20-2 | Details |
| Trimethoprim EP Impurity A | C15H20N4O3 | 213745-86-9 | Details |
| Levosimendan Impurity 10 | C11H12N2O2 | 134678-47-0 | Details |
| Finerenone | C21H22N4O3 | 1050477-31-0 | Details |
| (S)-Cetirizine Dihydrochloride | C21H26Cl2N2O3 | 163837-48-7 | Details |
| C18H20ClN3O4S | 721401-53-2 | Details |
| C15H21N5O8S2 | 102579-57-7 | Details |
| C6H6N2O3S | 82514-69-0 | Details |
| C19H21N3O | Details |
| C19H19N7O6 | Details |
| C8H13NO3 | 102849-49-0 | Details |
| CDP-082-SM2-imp H | C6H10O4 | 56766-77-9 | Details |
| C16H22N6O | 1640972-35-5 | Details |
| C13H14N2O5 | 295357-66-3 | Details |
| C9H18N2O2 | 1262340-21-5 | Details |
| C15H8Cl2F6N2O | 370-50-3 | Details |
| C11H18ClNO2 | 5178-52-9 | Details |
| 3-nitro-4-phenoxy-5-sulfobenzoic acid | C13H9NO8S | 751422-00-1 | Details |
| SulfaMethoxazole Related CoMpound F | C10H11N3O3S | 17103-52-5 | Details |
| 2-Chlorobenzoic acid | C7H5ClO2 | 118-91-2 | Details |
| C35H36F2N8O9S2 | 946075-13-4 | Details |
| C33H32O5 | 1329643-40-4 | Details |
| C22H22N6O7S2 | 97148-38-4 | Details |
| Details |
| C19H25ClN2O | 135755-51-0 | Details |
| C7H6O5S | 632-25-7 | Details |
| ETHYL-(3,4-DIMETHOXY-PHENYL)-AMINE | C10H15NO2 | 32953-13-2 | Details |
| Valsartan Isopropyl Ester | C27H35N5O3 | 1245820-09-0 | Details |
| Palmitic acid | C16H32O2 | 57-10-3 | Details |
| Finerenone Impurity 22 | C22H24N4O3 | 2640280-85-7 | Details |
| Loxoprofen Impurity E | C15H18O4 | 1091621-62-3 | Details |
| 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine-3-carboxamide | C21H20N4O3 | 2084136-51-4 | Details |
| Loxoprofen Impurity D | C15H18O5 | 1091621-61-2 | Details |
| 4-(4-cyano-2-methoxyphenyl)-5-methoxy-2,8-dimethyl-1,4-dihydro- 1,6-naphthyridine-3-carboxamide | C20H20N4O3 | 2640280-84-6 | Details |
| Mirabegron Impurity 10 | Details |
| C16H19N3O4S | 49841-96-5 | Details |
| C7H6ClN5 | 2095840-88-1 | Details |
| C7H8N6 | 1552277-18-5 | Details |
| N-(4-AMinobenzenesulfonyl) SulfaMethoxazole | C16H16N4O5S2 | 135529-16-7 | Details |
| 3-amino-4-hydroxy-5-nitrobenzoic acid | C7H6N2O5 | 267014-44-8 | Details |
| 3-nitro-4-phenoxybenzoic acid | C13H9NO5 | 202209-14-1 | Details |
| C8H9ClN2O2 | 1556190-62-5 | Details |
| Levocarnitine Impurity A | C7H14ClNO2 | 835638-57-8 | Details |
| Bumetanide Impurity 4 | C17H18N2O6S | 56106-56-0 | Details |
| 3,5-DINITRO-4-HYDROXYBENZOIC ACID | C7H4N2O7 | 41430-25-5 | Details |
| C14H7ClF2N4O2 | 936558-43-9 | Details |
| C10H9NO5 | 15371-06-9 | Details |
| C12H26ClN | 1250316-60-9 | Details |
| C12H11N3O5 | 1621182-18-0 | Details |
| C10H18N6O7P2 | 1425688-72-7 | Details |
| C11H11NO5 | 144841-10-1 | Details |
| C9H9NO4 | 103259-06-9 | Details |
| N,N-diethyl-2,2-difluoroacetamide | C6H11F2NO | 686-11-3 | Details |
| 3,5-diamino-4-phenoxybenzoic acid | C13H12N2O3 | 688318-18-5 | Details |
| C6H4ClN3O | 1781591-94-3 | Details |
| Product Total： Product Page： | ||||
| 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 | ||||